Article
Dual CRISPR/Cas9 correction of compound heterozygous MARS2 mutations in the iPSC line ISMMSi060-A from a patient with COXPD25.
Stem cell research - 1 Sept 2026
Liu Norman N, Baljinnyam Erdene, Hu Ruiqi, Salemi Sophia E, Webb Bryn D, Marro Samuele G
Abstract excerpt
We previously described the induced pluripotent stem cell (iPSC) line ISMMSi060-A derived from a patient with Combined Oxidative Phosphorylation Deficiency 25 (COXPD25) carrying compound heterozygous pathogenic variants in the mitochondrial methionyl-tRNA synthetase gene, MARS2. Here, we report the generation of the isogenic control line ISMMSi060-A-1 by CRISPR/Cas9-mediated correction of the MARS2 variants...
Read the complete abstract on PubMedTopics
- Humans
- Induced Pluripotent Stem Cells
- CRISPR-Cas Systems
- Mutation
- Heterozygote
- Cell Line
